Company / Assets per Share
Trevi Therapeutics, Inc. Assets per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.09
FY2024
5-year range
$0.90 / $2.61
FY2020-FY2024
Trend
+20.5%
vs FY2023
Sector context
#198 of 210
Health Care
What the data says
Among 210 Health Care companies, Trevi Therapeutics, Inc. is in the bottom 6% for assets per share. Assets per Share has fluctuated over the past 7 years, ranging from $0.90 in FY2023 to $24.05 in FY2018.
Based on SEC 10-K filings.
1.09 in FY2024 with a 5-year CAGR of -26.6%.
Declined from $1.91 to $1.09 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -13.6%
- 5-Year CAGR
- -26.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 210This company $1.09 Sector average $353.15
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2024, assets per share increased 20.5% year-over-year.
- Ranks #198 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2018.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.09 | +20.5% |
| FY2023 | $0.90 | -52.6% |
| FY2022 | $1.91 | +13.2% |
| FY2021 | $1.68 | -35.5% |
| FY2020 | $2.61 | -49.0% |
| FY2019 | $5.11 | -78.7% |
| FY2018 | $24.05 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026